Cargando…
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
The endocannabinoid (eCB) system encompasses the eCBs anandamide and 2-arachidonoylglycerol, their anabolic/catabolic enzymes, and the cannabinoid CB(1) and CB(2) receptors. Its expansion to include several eCB-like lipid mediators, their metabolic enzymes, and their molecular targets, forms the end...
Autor principal: | Di Marzo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605024/ https://www.ncbi.nlm.nih.gov/pubmed/33162769 http://dx.doi.org/10.31887/DCNS.2020.22.3/vdimarzo |
Ejemplares similares
-
The Gut Microbiome–Endocannabinoidome Axis: A New Way of Controlling Metabolism, Inflammation, and Behavior
por: Silvestri, Cristoforo, et al.
Publicado: (2023) -
Dietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
por: Castonguay-Paradis, Sophie, et al.
Publicado: (2023) -
Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint †
por: Schiano Moriello, Aniello, et al.
Publicado: (2022) -
Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
por: Di Marzo, Vincenzo, et al.
Publicado: (2019) -
Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice
por: Lacroix, Sébastien, et al.
Publicado: (2019)